Table 2.

Vasodilator stress perfusion CMR for the detection of CAD.

Study	Stressor(s)	Number of patients	MR-scanner	Definition of relevant stenosis (%)	Sensitivity (%) with 95%CI	Specificity (%) with 95%CI
Cury et al., 2006	Dipyridamole	47	GE 1.5T	≥70	87 (74–94)	89 (80–95)
Doyle et al., 2003	Dipyridamole	199	Philips 1.5T	≥70	58 (37–77)	78 (71–84)
Giang et al., 2004	Adenosine	44	GE 1.5T	≥50	93 (77–99)	75 (48–92)
Pennell et al., 1990	Dipyridamole	40	Picker 0.5T	Not specified	62 (45–77)	100 (3–100)
Ishida et al., 2003	Dipyridamole	104	GE 1.5T	≥70	90 (81–95)	85 (67–94)
Kawase et al., 2004	Nicorandil	50	Philips 1.5T	>70	94 (80–99)	94 (71–100)
Klem et al., 2006	Adenosine	95	Siemens 1.5T	≥70	89 (75–97)	87 (76–95)
Nagel et al., 2003	Adenosine	90	Philips 1.5T	≥75	88 (75–96)	90 (77–97)
Pilz et al., 2006	Adenosine	176	GE 1.5T	>70	96 (91–99)	83 (71–91)
Plein et al., 2004	Adenosine	71	Philips 1.5T	≥70	96 (88–100)	83 (52–98)
Plein et al., 2005	Adenosine	92	Philips 1.5T	>70	88 (77–95)	82 (52–90)
Sakuma et al., 2005	Dipyridamole	40	Siemens 1.5T	>70	81 (58–95)	68 (43–87)
Schwitter et al., 2001	Dipyridamole	48	GE 1.5T	≥50	87 (71–95)	85 (35–93)
Takase et al., 2004	Dipyridamole	102	GE 1.5T	>50	93 (85–98)	85 (65–96)
Paetsch et al., 2004	Adenosine	79	Philips 1.5T	>50	91 (79–97)	62 (41–80)
Pooled data	Vasodilator stress	1237			91 (88–94)	81 (77–85)